Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

<p>Metabolomics MeT5A isogenics</p>

Zapisane w:

Opis bibliograficzny
1. autor:	Sarah E. Barnett (15100356) (author)
Kolejni autorzy:	Jenna Kenyani (15100359) (author), Martina Tripari (15100362) (author), Zohra Butt (15100365) (author), Rudi Grosman (15100368) (author), Francesca Querques (15100371) (author), Liam Shaw (15100374) (author), Luisa C. Silva (15100377) (author), Zoe Goate (15100380) (author), Stefan J. Marciniak (15100383) (author), Doris M. Rassl (15100386) (author), Richard Jackson (15100389) (author), Lu-Yun Lian (15100392) (author), Peter W. Szlosarek (15100395) (author), Joseph J. Sacco (15100398) (author), Judy M. Coulson (15100401) (author)
Wydane:	2025
Hasła przedmiotowe:	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Clinical Research and Trials Methods and Technology Drug Resistance Regulation of gene expression in drug resistance Lung Cancer Metabolism Metabolic pathways Oncogenes & Tumor Suppressors Tumor suppressor genes Precision Medicine Preclinical Models In vitro models of cancer Proteomics
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy